Vertex Scores Key Analyst Upgrade on Top of Making an Acquisition
On top of the company announcing an acquisition on Tuesday, Vertex has seen a substantial analyst upgrade from Goldman Sachs.
On top of the company announcing an acquisition on Tuesday, Vertex has seen a substantial analyst upgrade from Goldman Sachs.
Medicines Co. shares made a handy gain on Tuesday after the firm announced results from its late-stage trial in the treatment of low-density lipoprotein cholesterol.
Mental illness is a pervasive problem nationwide. According to this infographic on mental health facts in America published by the National Alliance on Mental Illness. About one in five U.S. adults suffers from some…
Mallinckrodt is a pharmaceutical player that has been in trouble over its role in the opioid crisis in America. Investors have to wonder if the worst outcome is in the making.
A new device smaller than an oral thermometer uses nano-sensors to measure biomarkers in saliva to accurately predict the risk of heart disease or a heart attack. It then conveys information to users via…
Johnson & Johnson is trading higher on the news, but some smaller public companies tied into the opioid crisis are taking it on the chin.
The field of harmful algae blooms in Lake Erie has grown from 300 square miles to over 700 square miles in less than a month. The algae field, which makes up much of the…
The August 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
The August 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
One sector that has avoided much of the current trade and recession fear turmoil is health care, and especially the biotech companies. The four top stocks have gigantic implied upside.
Both Amgen and Celgene shares made a handy gain on Monday after it was announced that the companies had made an agreement in relation to Celgene’s merger with Bristol-Myers Squibb.
Here are three biotech stocks that recently saw their 50-day moving average cross above the 200-day average, a golden cross, plus two that went the other way.
FibroGen shares dipped slightly on Monday after the firm announced the passing of its CEO Thomas B. Neff over the weekend. An interim CEO has been named.
The State of New Jersey recently warned people not to swim in Lake Hopatcong, the state’s largest lake. In fact, people have been told not to touch it. Large parts of Lake Erie, one…
Medicines Company shares jumped early on Monday after the firm announced results from its late-stage cholesterol study of inclisiran.